United Therapeutics (UTHR)
(Delayed Data from NSDQ)
$353.00 USD
+1.67 (0.48%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $353.03 +0.03 (0.01%) 7:58 PM ET
3-Hold of 5 3
B Value F Growth C Momentum C VGM
United Therapeutics (UTHR) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$361.91 | $575.00 | $240.00 | 3.01% |
Price Target
Based on short-term price targets offered by 11 analysts, the average price target for United Therapeutics comes to $361.91. The forecasts range from a low of $240.00 to a high of $575.00. The average price target represents an increase of 3.01% from the last closing price of $351.33.
Analyst Price Targets (11)
Broker Rating
United Therapeutics currently has an average brokerage recommendation (ABR) of 1.85 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 13 brokerage firms. The current ABR compares to an ABR of 1.85 a month ago based on 13 recommendations.
Of the 13 recommendations deriving the current ABR, eight are Strong Buy, representing 61.54% of all recommendations. A month ago, Strong Buy represented 61.54%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 8 | 8 | 8 | 9 | 10 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 4 | 4 | 4 | 3 | 2 |
Sell | 1 | 1 | 1 | 1 | 1 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.85 | 1.85 | 1.85 | 1.69 | 1.54 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
9/3/2024 | BTIG | Julian Harrison | Hold | Hold |
8/1/2024 | H.C. Wainwright & Co. | Andrew S Fein | Strong Buy | Strong Buy |
8/1/2024 | LadenburgThalmann | Matthew L Kaplan | Strong Buy | Hold |
8/1/2024 | SVB Securities | Roanna Ruiz | Strong Buy | Strong Buy |
7/11/2024 | Cowen & Co. | Joseph Thome | Strong Buy | Strong Buy |
7/9/2024 | Argus Research Corp. | Jasper Hellweg | Strong Buy | Strong Buy |
7/8/2024 | UBS | Ashwani Verma | Strong Buy | Strong Buy |
6/27/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
6/12/2024 | Wells Fargo Securities | Tiago Fauth | Strong Buy | Strong Buy |
5/3/2024 | Goldman Sachs | Chris Shibutani | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.85 |
ABR (Last week) | 1.85 |
# of Recs in ABR | 13 |
Average Target Price | $361.91 |
LT Growth Rate | 11.10% |
Industry | Medical - Drugs |
Industry Rank by ABR | 82 of 253 |
Current Quarter EPS Est: | 6.33 |
UTHR FAQs
United Therapeutics Corporation (UTHR) currently has an average brokerage recommendation (ABR) of 1.85 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 13 brokerage firms.
The average price target for United Therapeutics Corporation (UTHR) is $361.91. The current on short-term price targets is based on 9 reports.
The forecasts for United Therapeutics Corporation (UTHR) range from a low of $240 to a high of $575. The average price target represents a increase of $3.01 from the last closing price of $351.33.
The current UPSIDE for United Therapeutics Corporation (UTHR) is 3.01%
Based on short-term price targets offered by 11 analysts, the average price target for United Therapeutics comes to $361.91. The forecasts range from a low of $240.00 to a high of $575.00. The average price target represents an increase of 3.01% from the last closing price of $351.33.